4196.0: Tuesday, November 18, 2003: 2:30 PM-4:00 PM | |||
Oral | |||
| |||
This session will explore the impact of corporate and industry influence on scientific research and public policy decision-making. The panelists will present several case studies that illustrate how undue corporate influence can interfere with objective scientific analysis and undermine efforts to have honest, balanced science guide public health policy. Following the presentations of these case studies, the panelists will then discuss remedies to safeguard the public’s health. | |||
Learning Objectives: At the end of this session, participants will be able to: 1. Describe the role of scientific research and advisory bodies in public policy decision-making. 2. Expose participants to the impact of the undue influence of corporate interests on scientific research and policy decision-making. 3. Describe specific cases in which bias and undue corporate influence have detrimentally influenced public decision making. 4. Identify resources, opportunities, and strategies for reform. | |||
See individual abstracts for presenting author's disclosure statement and author's information. | |||
Polly Hoppin, ScD Susan West Marmagas, MPH | |||
Michael Green, MS, MPP | |||
Politics of Science Michael Green, MS, MPP, Alise M. Cappel, Bruce Jennings, PhD, Ignacio H. Chapela, PhD, Lynn Goldman, MD, MPH | |||
"Advice Without Consent": Conflict of Interest in the Federal Scientific Advisory Committees Process Lynn Goldman, MD, MPH | |||
Impact of corporate interests on scientific research and reporting and the role of the public university Ignacio H. Chapela, PhD | |||
Misconduct of the California Hexavalent Chromium Blue Ribbon Panel Alise M. Cappel | |||
Science and Politics in California Environmental Policy: The Neglected Role of Public Health Bruce Jennings, PhD | |||
Organized by: | Environment | ||
Endorsed by: | Medical Care; Occupational Health and Safety | ||
CE Credits: | Environmental Health, Health Education (CHES), Pharmacy |